Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Advanced Nanomedicine: Redefining Therapeutic Paradigms for Inflammatory Bowel Disease
Yinfeng Zhang, Tingting Wang, Meng Sun, et al.
Advanced Healthcare Materials (2023) Vol. 12, Iss. 19
Closed Access | Times Cited: 21

Showing 21 citing articles:

Beyond Extracellular Vesicles: Hybrid Membrane Nanovesicles as Emerging Advanced Tools for Biomedical Applications
Meng Sun, Jiani Yang, Yueyun Fan, et al.
Advanced Science (2023) Vol. 10, Iss. 32
Open Access | Times Cited: 28
CD-MOFs: From preparation to drug delivery and therapeutic application
Yanxue Si, Huize Luo, Pai Zhang, et al.
Carbohydrate Polymers (2023) Vol. 323, pp. 121424-121424
Closed Access | Times Cited: 23
Precisely Inhibiting Excessive Intestinal Epithelial Cell Apoptosis to Efficiently Treat Inflammatory Bowel Disease with Oral Pifithrin‐α Embedded Nanomedicine (OPEN)
Mingyuan Wang, Qiong Huang, Min Liu, et al.
Advanced Materials (2023) Vol. 35, Iss. 49
Closed Access | Times Cited: 22
Analysis of nanomedicine applications for inflammatory bowel disease: structural and temporal dynamics, research hotspots, and emerging trends
Hongyu Jiang, Bo Shao, Hongda Wang, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
Orally delivered Prussian blue functionalized by olsalazine-conjugated hyaluronic acid for targeted combination therapy of ulcerative colitis
Tong Tong, Ronghua Zhao, Yanyun Yang, et al.
Nano Today (2025) Vol. 61, pp. 102642-102642
Closed Access
Immunotherapy strategy for treating inflammatory bowel disease based on a nanozyme/total glucosides of paeony hybrid materials
Zetian Wang, Ningning Hu, Longqiu Yang, et al.
Advanced Composites and Hybrid Materials (2025) Vol. 8, Iss. 1
Open Access
Recent advances on emerging nanomaterials for diagnosis and treatment of inflammatory bowel disease
Wanyue Fu, Lingling Xu, Z Chen, et al.
Journal of Controlled Release (2023) Vol. 363, pp. 149-179
Closed Access | Times Cited: 19
Challenges and opportunities in inflammatory bowel disease: from current therapeutic strategies to organoid-based models
Lingjie Kong, Siyan Chen, Shenghao Huang, et al.
Inflammation Research (2024) Vol. 73, Iss. 4, pp. 541-562
Closed Access | Times Cited: 5
Scale‐Up Preparation of Manganese‐Iron Prussian Blue Nanozymes as Potent Oral Nanomedicines for Acute Ulcerative Colitis
Chengyun Hu, Yuan Xue, Ronghua Zhao, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 16
Closed Access | Times Cited: 5
Extracellular Vesicles from Nanomedicine‐Trained Intestinal Microbiota Substitute for Fecal Microbiota Transplant in Treating Ulcerative Colitis
Menghang Zu, Ga Liu, Haiting Xu, et al.
Advanced Materials (2024) Vol. 36, Iss. 41
Open Access | Times Cited: 4
Enteric-coated cerium dioxide nanoparticles for effective inflammatory bowel disease treatment by regulating the redox balance and gut microbiome
Yubiao Huang, Jiaqi Xu, Ge Sun, et al.
Biomaterials (2024) Vol. 314, pp. 122822-122822
Closed Access | Times Cited: 3
Reactive Oxygen Species Triggered Cleavage of Thioketal‐Containing Supramolecular Nanoparticles for Inflammation‐Targeted Oral Therapy in Ulcerative Colitis
Ting Xiong, Huipeng Xu, Qin Nie, et al.
Advanced Functional Materials (2024)
Closed Access | Times Cited: 1
Β-Cyclodextrin-based materials for 3D printing, cancer therapy, tissue engineering, and wound healing
Malairaj Sathuvan, Sun-Hong Min, Karthikeyan Narayanan, et al.
Chemical Engineering Journal (2024), pp. 157272-157272
Closed Access | Times Cited: 1
Upregulation of MMP9 and ORM2 leading to increased neutrophil infiltration as a potential common mechanism in the development of IBD and MDD
Jiangnan Sun, Ruicheng Gao, Jie Hu, et al.
Research Square (Research Square) (2024)
Open Access
IGF2 contributes to the immunomodulatory effects of exosomes from endometrial regenerative cells on experimental colitis
Qiang Chen, Bo Shao, Yini Xu, et al.
International Immunopharmacology (2024) Vol. 140, pp. 112825-112825
Open Access
Bioinspired and bioderived nanomedicine for inflammatory bowel disease
Rafaela Gazzi, Rita Gelli, Simone Aleandri, et al.
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2024) Vol. 16, Iss. 4
Open Access
Neutrophil Hitchhiking Enhances Liposomal Dexamethasone Therapy of Sepsis
Rashmi V. Mathur, Sara El-Safy, Adrian T. Press, et al.
ACS Nano (2024) Vol. 18, Iss. 42, pp. 28866-28880
Closed Access
Cell-derived biomimetic drug delivery system for inflammatory bowel disease therapy
Wenjing Yang, Peihong Lin, Rui Gao, et al.
Materials Today Bio (2024) Vol. 29, pp. 101332-101332
Open Access
Delivery of Encapsulated Intelligent Engineered Probiotic for Inflammatory Bowel Disease Therapy
Zhen‐Ping Zou, Zhihao Cai, Xiao Peng Zhang, et al.
Advanced Healthcare Materials (2024)
Closed Access
Nanomedicine: The new trend and future of precision medicine for inflammatory bowel disease
Huanyu Li, Meng Pan, Yifan Li, et al.
Chinese Medical Journal (2024)
Open Access
ROS Regulation in CNS Disorder Therapy: Unveiling the Dual Roles of Nanomedicine
Zhengyang Quan, Sa Wang, Huanhuan Xie, et al.
Small (2024)
Closed Access
Oral Lactoferrin‐Responsive Formulation Anchoring around Inflammatory Bowel Region for IBD Therapy
Jinfan Yang, Ning Shang, Zhengqing Li, et al.
Advanced Healthcare Materials (2024)
Closed Access
Page 1

Scroll to top